LA HB403 | 2024 | Regular Session
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Enrolled on May 8 2024 - 75% progression
Action: 2024-05-09 - Sent to the Governor for executive approval.
Text: Latest bill text (Enrolled) [PDF]
Status: Enrolled on May 8 2024 - 75% progression
Action: 2024-05-09 - Sent to the Governor for executive approval.
Text: Latest bill text (Enrolled) [PDF]
Summary
Adds drugs prescribed for certain ocular conditions to the listing of prescription drugs exempt from local sales and use taxes (EN DECREASE LF RV See Note)
Title
Adds drugs prescribed for certain ocular conditions to the listing of prescription drugs exempt from local sales and use taxes (EN DECREASE LF RV See Note)
Sponsors
Roll Calls
2024-05-07 - Senate - Senate Vote on HB 403 FINAL PASSAGE (#553) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2024-03-20 - House - House Vote on HB 403 FINAL PASSAGE (#52) (Y: 104 N: 0 NV: 0 Abs: 1) [PASS]
2024-03-20 - House - House Vote on HB 403 FINAL PASSAGE (#52) (Y: 104 N: 0 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-09 | House | Sent to the Governor for executive approval. |
| 2024-05-08 | Senate | Signed by the President of the Senate. |
| 2024-05-08 | House | Enrolled and signed by the Speaker of the House. |
| 2024-05-07 | House | Received from the Senate without amendments. |
| 2024-05-07 | Senate | Rules suspended. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. |
| 2024-04-24 | Senate | Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. |
| 2024-04-23 | Senate | Read by title and referred to the Legislative Bureau. |
| 2024-04-22 | Senate | Reported favorably. |
| 2024-03-25 | Senate | Read second time by title and referred to the Committee on Revenue and Fiscal Affairs. |
| 2024-03-20 | Senate | Received in the Senate. Rules suspended. Read first time by title and placed on the Calendar for a second reading. |
| 2024-03-20 | House | Read third time by title, roll called on final passage, yeas 104, nays 0. Finally passed, title adopted, ordered to the Senate. |
| 2024-03-19 | House | Scheduled for floor debate on 03/20/2024. |
| 2024-03-19 | House | Read by title, ordered engrossed, passed to 3rd reading. |
| 2024-03-18 | House | Reported favorably (16-0). |
| 2024-03-11 | House | Read by title, under the rules, referred to the Committee on Ways and Means. |
| 2024-02-29 | House | Under the rules, provisionally referred to the Committee on Ways and Means. |
| 2024-02-29 | House | Prefiled. |
